Kazia Therapeutics Limited

US$7.18As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:KZIAHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (31.28%)
Div yield —
ROE (106.90%)
Biotechnology
Beta (5Y) 2.36
PE TTM —
TSR TTM (8.07%)
Mkt cap US$98.39M
ROIC (53.34%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$7.61
5.95%
(34.61%)
Hold 4|3|10|8|2
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.19
0.19
0.19
0.21
27.89%
24.87%
13.44%
20.31%
Revenue$M
10.78
11.37
11.33
11.83
11.63%
14.18%
13.30%
15.64%
Peers (US$98.39M)
Cap (US$)
PE
107.6M
—
Capital
TTM
5Y
10Y
Leveragex
0.555
1.148
1.164
EBIT/Intx
0.880
0.246
0.229
Own earn%
246.88
(128.81)
(111.39)
Sh yield%
33.98
41.18
45.08
Owners
Insiders/Inst%
7.72
82.64
Short interest%
3.41
SBC / revenue%
3.26
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
21–28
$1 testx
—
Incr. ROIC%
2